Outside of stroke, tDCS has had major setbacks in recent years. The DepressionDC study found it to be no better than sham as ...

Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...

MicroTransponder recently announced positive real-world outcomes for its Vivistim vagus nerve stimulation (VNS) system.

Mild electrical brain stimulation did not further improve motor recovery in stroke survivors, according to late-breaking science presented today at the American Stroke Association's International ...

Neither a placebo procedure nor two different doses of transcranial brain stimulation, which send electrical signals through ...

This important study shows that the activity of hypothalamic hypocretin/orexin neurons (HONs) correlates with body movement over multiple behaviors. Sophisticated techniques and analyses showcase this ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

MPs from the Labour Party, Conservatives, Liberal Democrats, and Green Party have come together to back a new amendment to the Terminally Ill Adults (End of Life) Bill to allow those with ...

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

Boosting communication between the spinal nerves and the muscles using the spinal cord stimulation reverses spinal muscle atrophy (SMA) progression and could be applied to other motoneuron diseases, ...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.